The experimental results showed that Smyd-2 knockout could reduce the cerebral infarction volume, improve the neurologic deficit scores, alleviate neuronal demyelination, and reduce the number of degenerative neurons in the hippocampus after CIR (Figure 2B,C,E). Here, SMYD2 is linked to cerebral infarction.